E-LIB Suche - Ergebnisse für: van Wijk, Rob C.

1

Risk Factors for COVID-19 and Respiratory Tract Infections ..:

Mockeliunas, Laurynas ; van Wijk, Rob C. ; Upton, Caryn M....
Vaccines. 12 (2024) 3 - p. 329 , 2024

2

Pharmacokinetic analysis across studies to drive knowledge‐..:

van Wijk, Rob C. ; Imperial, Marjorie Z. ; Savic, Radojka M..
CPT: Pharmacometrics & Systems Pharmacology. 12 (2023) 9 - p. 1187-1200 , 2023

Link: https://doi.org/10.1002/..

3

Seasonal influence on respiratory tract infection severity ..:

van Wijk, Rob C. ; Mockeliunas, Laurynas ; Upton, Caryn M....
CPT: Pharmacometrics & Systems Pharmacology. 12 (2023) 9 - p. 1250-1261 , 2023

Link: https://doi.org/10.1002/..

4

Reproducibility in pharmacometrics applied in a phase III t..:

van Wijk, Rob C. ; Mockeliunas, Laurynas ; van den Hoogen, Gerben...
Scientific Reports. 13 (2023) 1 - p. , 2023

Link: https://doi.org/10.1038/..

5

Implementing best practices on data generation and reportin..:

van Wijk, Rob C. ; Lucía, Ainhoa ; Sudhakar, Pavan Kumar...
iScience. 26 (2023) 4 - p. 106411 , 2023

Link: https://doi.org/10.1016/..

6

Standards for model-based early bactericidal activity analy..:

Mockeliunas, Laurynas ; Faraj, Alan ; van Wijk, Rob C....
Frontiers in Pharmacology. 14 (2023) - p. , 2023

Link: https://doi.org/10.3389/..

7

Model‐informed pediatric dose selection of marzeptacog alfa..:

Faraj, Alan ; van Wijk, Rob C. ; Neuman, Linda...
CPT: Pharmacometrics & Systems Pharmacology. 12 (2023) 7 - p. 977-987 , 2023

Link: https://doi.org/10.1002/..

8

Translational predictions of phase 2a first-in-patient effi..:

Ernest, Jacqueline P. ; Goh, Janice Jia Ni ; Strydom, Natasha...
European Respiratory Journal. 62 (2023) 2 - p. 2300165 , 2023

Link: https://doi.org/10.1183/..

9

Finding the right hazard function for time‐to‐event modelin..:

Van Wijk, Rob C. ; Simonsson, Ulrika S. H.
CPT: Pharmacometrics & Systems Pharmacology. 11 (2022) 8 - p. 991-1001 , 2022

Link: https://doi.org/10.1002/..

10

Safety and efficacy of BCG re-vaccination in relation to CO..:

Upton, Caryn M. ; van Wijk, Rob C. ; Mockeliunas, Laurynas...
eClinicalMedicine. 48 (2022) - p. 101414 , 2022

Link: https://doi.org/10.1016/..

11

Model-Informed Drug Discovery and Development Strategy for ..:

van Wijk, Rob C. ; Ayoun Alsoud, Rami ; Lennernäs, Hans.
Applied Sciences. 10 (2020) 7 - p. 2376 , 2020

Link: https://doi.org/10.3390/..

12

Anti‐tuberculosis effect of isoniazid scales accurately fro..:

van Wijk, Rob C. ; Hu, Wanbin ; Dijkema, Sharka M....
British Journal of Pharmacology. 177 (2020) 24 - p. 5518-5533 , 2020

Link: https://doi.org/10.1111/..

13

Quantification of Natural Growth of Two Strains of Mycobact..:

Van Wijk, Rob C. ; van der Sar, Astrid M. ; Krekels, Elke H.J....
Clinical and Translational Science. 13 (2020) 6 - p. 1060-1064 , 2020

Link: https://doi.org/10.1111/..

14

Impact of post-hatching maturation on the pharmacokinetics ..:

van Wijk, Rob C. ; Krekels, Elke H. J. ; Kantae, Vasudev...
Scientific Reports. 9 (2019) 1 - p. , 2019

Link: https://doi.org/10.1038/..

15

Development of a population pharmacokinetic model to predic..:

Wong, Yin Cheong ; Ilkova, Trayana ; van Wijk, Rob C...
European Journal of Pharmaceutical Sciences. 111 (2018) - p. 514-525 , 2018

Link: https://doi.org/10.1016/..